Core Insights - The 8th China International Import Expo (CIIE) is being held in Shanghai from November 5 to 10, 2023, with the theme "New Era, Shared Future," showcasing 461 new products, technologies, and services across six major exhibition areas [1][3] - CIIE serves as a platform for promoting international economic cooperation and mutual benefits, injecting positive energy into both the Chinese and global economies [1] - Amway, celebrating its 30th anniversary in China, is leveraging CIIE to showcase its health products and solutions, emphasizing its commitment to the Chinese market [1][3] Company Strategy - Amway's Chairman and President, Yu Fang, highlighted the expo's role in enhancing global companies' confidence in investing in China, positioning the country as a strategic market for Amway [3][9] - The company plans to continue increasing its investment in China, focusing on expanding and enhancing its supply chain to contribute to the modernization of the industrial system [3][11] Product Innovation - Amway is using CIIE as a platform to launch innovative products, including those centered around plant nutrients and health solutions, addressing consumer demands for balanced nutrition and health management [4][6] - The company has established a plant research center in Wuxi, China, and is integrating AI technology to develop new health solutions [6][8] Investment Plans - Amway has initiated a five-year investment plan amounting to 2.1 billion RMB, aimed at upgrading its operations in China, including production facilities, digital infrastructure, and experience centers [13] - The investment will also focus on research and development, including organic farming and plant anti-aging research [13] Market Position - Amway has been operating in China for 30 years and has consistently aligned its growth with China's economic development, making it the largest market for the company globally for 22 consecutive years [9][11] - The company views China as a strategic growth engine and is committed to long-term investment in the market, reflecting its belief in the opportunities presented by the Chinese economy [11][13]

Core Insights - The 8th China International Import Expo (CIIE) is being held in Shanghai from November 5 to 10, showcasing 461 new products, technologies, and services across six major exhibition areas, emphasizing the importance of international trade cooperation and mutual benefits [1][2] - Amway China is leveraging the CIIE to highlight its commitment to health products and services, showcasing innovative solutions to meet the diverse health needs of the public [2][3] Group 1: CIIE Overview - The CIIE serves as a platform for global enterprises to tap into the Chinese market, promoting international economic cooperation and injecting positive energy into both the Chinese and global economies [1] - The event features new themes such as the silver economy, ice and snow economy, and sports economy, along with new consumption platforms focusing on digital and health consumption [1] Group 2: Amway's Commitment and Innovations - Amway China is focusing on health consumption, launching a new multi-vitamin and mineral powder product, "Little Gold Powder," which is the first "blue hat" multi-nutrient product in the Chinese market [3] - The company is showcasing a range of anti-aging products aimed at improving health expectancy, including solutions for cellular health, mobility, brain function, and skin health [3] Group 3: Research and Development - Amway has established a plant research center in Wuxi, integrating traditional Chinese medicine with modern biomedical approaches through its "Shennong" system, which includes extensive data on herbal remedies and health solutions [4] - The company is building a comprehensive local research and development system for traditional Chinese medicine, collaborating with various institutions to innovate and modernize agricultural practices [4] Group 4: Investment Plans - Amway has initiated a five-year investment plan of 2.1 billion RMB (approximately 0.3 billion USD) from 2023 to 2027, focusing on upgrading production facilities, enhancing digital infrastructure, and expanding experience centers [6] - The investment plan aims to strengthen Amway's supply chain and innovation capabilities in China, reinforcing its position as a strategic growth engine [6] Group 5: Strategic Alignment - Amway's strategies align with China's national goals of health and well-being, emphasizing digital infrastructure upgrades and a robust supply chain to support the health and wellness sector [7] - The company has successfully transitioned to a "second entrepreneurship" in China, with innovations and business models developed in China being adopted in other markets [7]

Core Insights - The China International Import Expo (CIIE) is increasingly recognized as a platform for promoting international trade cooperation and mutual benefits, contributing positively to both the Chinese and global economies [1] Company Highlights - Amway, celebrating 30 years in China, showcased its health products and services at the CIIE, addressing the diverse health needs of the public through innovative solutions and research achievements [2] - Amway's Chairman and President, Yu Fang, emphasized the expo's role in enhancing global companies' confidence in investing in China, positioning the country as a strategic market for Amway [4] - Amway launched a new product, a multi-vitamin and mineral powder called "Little Gold Powder," aimed at addressing nutritional imbalances in the Chinese diet, marking it as the first "blue hat" multi-nutrient powder in the market [5] Product Innovations - Amway presented a range of anti-aging products focused on improving healthspan, utilizing plant-based nutrients to enhance quality of life [7] - The company also highlighted products targeting metabolic health, dietary balance, and weight management, showcasing a comprehensive approach to health solutions [8] - Amway's Nutrilite brand is centered on plant nutrients, with significant investments in research and development, including a plant research center in Wuxi and the integration of AI technology for product development [8][10] Investment and Growth Strategy - Amway has initiated a five-year investment plan of 2.1 billion yuan (approximately 300 million USD) from 2023 to 2027, focusing on upgrading production facilities, digital infrastructure, and enhancing research capabilities [13] - The company aims to strengthen its supply chain and innovation capabilities in China, reinforcing its position as a strategic growth engine [14] - Amway's long-term commitment to the Chinese market is evident, with a focus on aligning its development with national strategies for health and well-being [12][14]